2023-11-15T12:41:08-06:00 2022-12-31 561031342 WILLIAMS OVERMAN PIERCE LLP 328 E MARKET STREET SUITE 100 GREENSBORO NC 27401 990 2022-01-01 812849764 GLIOBLASTOMA FOUNDATION INC GLIO 9193091489 2451 CROASDAILE FARM PARKWAY 109 DURHAM NC 27705 MADAN KWATRA SECRETARY/TREASURER 9193091489 2023-11-15 1 MADAN KWATRA 999009999 0 MARYELLEN PRANCE CPA P01662078 3362751686 2023-11-15 X 0 AAL1 IAL1 2022 2023-04-26 12:10:37Z MADAN KWATRA 2451 CROASDAILE FARM PARKWAY 109 DURHAM NC 27705 1966854 0 X WWW.GLIOBLASTOMAFOUNDATION.ORG X 2016 NC AS THE FIRST AND LEADING NATIONAL NONPROFIT DEVOTED TO GLIOBLASTOMA, THE MISSION OF THE GLIOBLASTOMA FOUNDATION IS TO FUND LEADING-EDGE RESEARCH FOR A CURE FOR GLIOBLASTOMA, PROVIDE PATIENT SUPPORT RESOURCES, AND RAISE AWARENESS OF THIS RARE, GRADE 4 BRAIN CANCER. 3 2 5 10 0 0 1302093 1513382 0 0 -48519 -41832 0 0 1253574 1471550 127000 180000 0 0 237551 262769 10359 0 21019 328441 410809 703351 853578 550223 617972 1523936 1781399 0 0 1523936 1781399 X AS THE FIRST AND LEADING NATIONAL NONPROFIT DEVOTED TO GLIOBLASTOMA, THE MISSION OF THE GLIOBLASTOMA FOUNDATION IS TO FUND LEADING-EDGE RESEARCH FOR A CURE FOR GLIOBLASTOMA, PROVIDE PATIENT SUPPORT RESOURCES, AND RAISE AWARENESS OF THIS RARE, GRADE 4 BRAIN CANCER. 0 0 605314 180000 THE RESEARCH ACHIEVEMENTS OF THE GLIOBLASTOMA FOUNDATION IN 2022 INVOLVED CONTINUING FUNDING FOR LEADING EDGE RESEARCH FOR TARGETED TREATMENTS FOR GLIOBLASTOMA, PROVIDING PATIENT SUPPORT RESOURCES FOR FAMILIES AND PATIENTS DIAGNOSED WITH GLIOBLASTOMA, AND RAISING AWARENESS OF THIS RARE GRADE 4 BRAIN CANCER. DURING THE 2022 YEAR WE CONTINUED TO FUND RESEARCH FOR THE COMBINATION DRUG THERAPY OF LOMUSTINE AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS, FUNDED RESEARCH INTO PATIENT AND CAREGIVER QUALIFY OF LIFE AFTER DIAGNOSIS RESEARCH, AND A TARGETED RESEARCH STUDY ON GLIOBLASTOMA CANCER CELL METABOLISM PROCESSES AND DRUGS TO STOP GLIOBLASTOMA CELL GROWTH. WE ALSO MOVED FORWARD ON OUR GOAL TO MANUFACTURE LOMUSTINE AT A REDUCED RATE FOR PATIENTS BY PARTNERING WITH CONTINUITY PHARMA IN THE PRODUCTIVE OF LOMUSTINE ACTIVE PHARMACEUTICAL INGREDIENT. THIS PROJECT IS CURRENTLY UNDERWAY TO BRING LOMUSTINE TO PATIENTS AT A LOWER COST. WE ALSO CONTINUED OUR PATIENT PROGRAMS TO PROVIDE CLINICAL TRIALS MATCHING TO PATIENTS AFTER A GLIOBLASTOMA DIAGNOSIS AND CONTINUED TO HOST OUR AWARD-WINNING SUPPORT GROUP FOR PATIENTS AND CAREGIVERS, CALLED THE GLIOBLASTOMA SUPPORT CIRCLE. 605314 1 1 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 5 1 0 0 0 0 0 0 0 0 0 0 0 0 X 3 2 1 0 0 0 0 0 0 1 0 0 0 1 1 1 1 1 1 1 0 0 X MADAN KWATRA 9194021775 2451 CROASDAILE FARM PARKWAY 109 DURHAM NC 27705 NEELAM KWATRA PRESIDENT 4.00 X X 0 0 0 MADAN KWATRA TREASURER/SECRETARY 4.00 X X 0 0 0 GITA KWATRA CEO 40.00 X X 202250 0 18999 202250 0 18999 1 0 1 0 FINNEGAN HENDERSON FARABOW GARRETT 901 NEW YORK AVENUE NW WASHINGTON DC 20001 LEGAL SERVICES 132316 1 1513382 1513382 14333 14333 439139 495304 -56165 -56165 -56165 1471550 0 0 -41832 180000 180000 192826 183187 9639 69943 66446 3497 132316 132316 91507 91507 53161 38730 14431 29229 22641 6588 49240 49240 11614 11614 1058 1058 CONTRACT SERVICES 26665 26665 BANK FEES 8661 8661 MISCELLANEOUS 4280 4280 MEALS AND ENTERTAINMENT 2399 2399 679 679 853578 605314 227245 21019 698213 1034846 0 18250 5290 1394 4954 3896 820769 724407 1523936 1781399 0 0 X 1523936 1781399 1523936 1781399 1523936 1781399 617972 -360509 0 X X 1 X 0 1 0 X 313448 448677 842093 1302093 1513382 4419693 313448 448677 842093 1302093 1513382 4419693 4419693 4227 9185 14333 27745 4447438 0.99380 0.97770 X FORM 990 SCHEDULE A, PART II, SECTION B, LINE 8 LINE 8 WAS UPDATED FOR 2020 AND 2021 TO REMOVE THE GAIN AND LOSS ON THE SALE OF SECURITIES. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 5290 1394 3896 3896 ETRADE 724407 F 724407 1 DUKE UNIVERSITY HOSPITAL PO BOX 90581 DURHAM NC 27708 560532129 90000 0 GLIOBLASTOMA RESEARCH THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLOCOMBE BLVD HOUSTON TX 770304009 746001118 40000 0 GLIOBLASTOMA RESEARCH TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 615 W 131ST STREET 8741 NEW YORK NY 10027 911859360 50000 0 GLIOBLASTOMA RESEARCH 3 X 0 0 0 0 0 0 0 0 0 GITA KWATRA CEO 202250 0 0 0 0 0 11354 0 7645 0 221249 0 0 0 FORM 990, PART VI, SECTION A, LINE 2 ALL MEMBERS OF THE BOARD ARE FAMILY MEMBERS. FORM 990, PART VI, SECTION A, LINE 8B THE ORGANIZATION DID NOT HAVE COMMITTEES. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS AVAILABLE TO THE ORGANIZATION'S ENTIRE GOVERNING BODY AND BOARD MEMBERS. FORM 990 IS REVIEWED BY THE ORGANIZATION'S PRESIDENT AND TREASURER BEFORE IT IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C EMPLOYEES AND DIRECTORS ARE REQUIRED TO DISCLOSE CONFLICT OF INTERESTS WHEN THEY ARISE AND ARE REQUIRED TO FILE AN ANNUAL DISCLOSURE FORM. FORM 990, PART VI, SECTION B, LINE 15A COMPENSATION IS IN ACCORDANCE WITH NATIONAL STANDARDS FOR OTHER HEALTHCARE NONPROFITS. FORM 990, PART VI, SECTION C, LINE 18 TAX RETURNS ARE AVAILABLE FOR PUBLIC INSPECTION ON THE GUIDESTAR WEBSITE. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION CURRENTLY DOES NOT MAKE A CONFLICT OF INTEREST POLICY AVAILABLE TO THE PUBLIC. FORM 990, PART XII, LINE 2C: THIS PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.